Purdue Pharma and Sackler Family Reach $7.4 Billion Settlement Over Opioid Crisis
Purdue Pharma and Sackler family agree to a $7.4 billion settlement to address opioid crisis lawsuits, subject to court approval.

Sackler, Purdue Pharma $7 billion lawsuit: Who's entitled to payment

Purdue Pharma, Sacklers reach new settlement agreement in opioid cases

Purdue Pharma, Sacklers to pay $7.4bn in new opioid settlement

Purdue and Sackler family agree $7.4bn OxyContin settlement
Overview
Purdue Pharma and the Sackler family have agreed to pay up to $7.4 billion to settle lawsuits related to the opioid crisis, significantly increasing their previous settlement by over $1 billion. The Sacklers will contribute $6.5 billion and Purdue $900 million. This deal aims to compensate victims and fund opioid addiction treatment, but requires court approval. The arrangement ends Sackler control over Purdue and restricts them from selling opioids in the U.S. Several state attorney generals participated in this negotiation, seeing it as a means to provide some closure to opioid crisis victims.
Analysis
Analysis unavailable for this viewpoint.